Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43

REFERENCES

• Alexander, W. S., R. Starr, J. E. Fenner, C. L. Scott, E. Handman, N. S. Sprigg, J. E. Corbin, A. L. Cornish, R. Darwiche, C. M. Owczarek, T. W. Kay, N. A. Nicola, P. J. Hertzog, D. Metcalf, and D. J. Hilton. 1999. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98:597–608.
   PubMed Web of Science ®Google Scholar
• Alonzi, T., D. Maritano, B. Gorgoni, G. Rizzuto, C. Libert, and V. Poli. 2001. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation in the liver. Mol. Cell. Biol. 21:1621–1632.
   PubMed Web of Science ®Google Scholar
• Auernhammer, C. J., C. Bousquet, and S. Melmed. 1999. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc. Natl. Acad. Sci. USA 96:6964–6969.
   PubMed Web of Science ®Google Scholar
• Barouki, F. M., F. R. Witter, D. E. Griffin, P. I. Nadler, A. Woods, D. L. Wood, and P. S. Lietman. 1987. Time course of interferon levels, antiviral state, 2′,5′-oligoadenylate synthetase and side effects in healthy men. J. Interferon Res. 7:29–39.
   PubMedGoogle Scholar
• Chen, L., I. Borozan, J. Feld, J. Sun, L. L. Tannis, C. Coltescu, J. Heathcote, A. M. Edwards, and I. D. McGilvray. 2005. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128:1437–1444.
   PubMed Web of Science ®Google Scholar
• Croker, B. A., D. L. Krebs, J. G. Zhang, S. Wormald, T. A. Willson, E. G. Stanley, L. Robb, C. J. Greenhalgh, I. Forster, B. E. Clausen, N. A. Nicola, D. Metcalf, D. J. Hilton, A. W. Roberts, and W. S. Alexander. 2003. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4:540–545.
   PubMed Web of Science ®Google Scholar
• Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739–1742.
   PubMed Web of Science ®Google Scholar
• Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277:1630–1635.
   PubMed Web of Science ®Google Scholar
• Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415–1421.
   PubMed Web of Science ®Google Scholar
• Der, S. D., A. Zhou, B. R. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:15623–15628.
   PubMed Web of Science ®Google Scholar
• Ejrnaes, M., C. M. Filippi, M. M. Martinic, E. M. Ling, L. M. Togher, S. Crotty, and M. G. von Herrath. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203:2461–2472.
   PubMed Web of Science ®Google Scholar
• Fried, M. W., M. L. Shiffman, K. R. Reddy, C. Smith, G. Marinos, F. L. Goncales, Jr., D. Haussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman, and J. Yu. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347:975–982.
   PubMed Web of Science ®Google Scholar
• Friedman, R. M. 2008. Clinical uses of interferons. Br. J. Clin. Pharmacol. 65:158–162.
   PubMed Web of Science ®Google Scholar
• Heim, M. H. 2000. Intracellular signalling and antiviral effects of interferons. Dig. Liver Dis. 32:257–263.
   PubMedGoogle Scholar
• Heim, M. H. 1999. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. J. Recept. Signal Transduct. Res. 19:75–120.
   PubMed Web of Science ®Google Scholar
• Heim, M. H., G. Gamboni, C. Beglinger, and K. Gyr. 1997. Specific activation of AP-1 but not Stat3 in regenerating liver in mice. Eur. J. Clin. Investig. 27:948–955.
   PubMed Web of Science ®Google Scholar
• Heim, M. H., I. M. Kerr, G. R. Stark, and J. E. Darnell, Jr. 1995. Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science 267:1347–1349.
   PubMed Web of Science ®Google Scholar
• Heim, M. H., D. Moradpour, and H. E. Blum. 1999. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J. Virol. 73:8469–8475.
   PubMed Web of Science ®Google Scholar
• Horvath, C. M. 2000. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem. Sci. 25:496–502.
   PubMed Web of Science ®Google Scholar
• Isaacs, A., and J. Lindenmann. 1957. Virus interference. I. The interferon. Proc. R. Soc. London B Biol. Sci. 147:258–267.
   PubMed Web of Science ®Google Scholar
• Ito, S., P. Ansari, M. Sakatsume, H. Dickensheets, N. Vazquez, R. P. Donnelly, A. C. Larner, and D. S. Finbloom. 1999. Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 93:1456–1463.
   PubMed Web of Science ®Google Scholar
• Kim, J. H., J. K. Luo, and D. E. Zhang. 2008. The level of hepatitis B virus replication is not affected by protein ISG15 modification but is reduced by inhibition of UBP43 (USP18) expression. J. Immunol. 181:6467–6472.
   PubMedGoogle Scholar
• Kim, K. I., M. Yan, O. Malakhova, J. K. Luo, M. F. Shen, W. Zou, J. C. de la Torre, and D. E. Zhang. 2006. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol. Cell. Biol. 26:472–479.
   PubMedGoogle Scholar
• Knobeloch, K. P., O. Utermohlen, A. Kisser, M. Prinz, and I. Horak. 2005. Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice. Mol. Cell. Biol. 25:11030–11034.
   PubMedGoogle Scholar
• Krebs, D. L., and D. J. Hilton. 2001. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378–387.
   PubMed Web of Science ®Google Scholar
• Larner, A. C., A. Chaudhuri, and J. E. Darnell, Jr. 1986. Transcriptional induction by interferon. New protein(s) determine the extent and length of the induction. J. Biol. Chem. 261:453–459.
   PubMed Web of Science ®Google Scholar
• Lauer, G. M., and B. D. Walker. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345:41–52.
   PubMed Web of Science ®Google Scholar
• Leyssen, P., C. Drosten, M. Paning, N. Charlier, J. Paeshuyse, E. De Clercq, and J. Neyts. 2003. Interferons, interferon inducers, and interferon-ribavirin in treatment of flavivirus-induced encephalitis in mice. Antimicrob. Agents Chemother. 47:777–782.
   PubMed Web of Science ®Google Scholar
• Li, X. L., J. A. Blackford, C. S. Judge, M. Liu, W. Xiao, D. V. Kalvakolanu, and B. A. Hassel. 2000. RNase-l-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response. J. Biol. Chem. 275:8880–8888.
   PubMed Web of Science ®Google Scholar
• Liu, B., J. Liao, X. Rao, S. A. Kushner, C. D. Chung, D. D. Chang, and K. Shuai. 1998. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95:10626–10631.
   PubMed Web of Science ®Google Scholar
• Liu, L. Q., R. Ilaria, Jr., P. D. Kingsley, A. Iwama, R. A. van Etten, J. Palis, and D. E. Zhang. 1999. A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation. Mol. Cell. Biol. 19:3029–3038.
   PubMed Web of Science ®Google Scholar
• Luik, A., S. Knapp, M. Thursz, H. C. Thomas, and J. F. Schlaak. 2004. Autoregulatory role of interleukin-10 in hepatitis C patients treated with IFN-alpha. J. Interferon Cytokine Res. 24:585–593.
   PubMedGoogle Scholar
• Malakhov, M. P., O. A. Malakhova, K. I. Kim, K. J. Ritchie, and D. E. Zhang. 2002. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277:9976–9981.
   PubMed Web of Science ®Google Scholar
• Malakhova, O., M. Malakhov, C. Hetherington, and D. E. Zhang. 2002. Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3. J. Biol. Chem. 277:14703–14711.
   PubMedGoogle Scholar
• Malakhova, O. A., K. I. Kim, J. K. Luo, W. Zou, K. G. Kumar, S. Y. Fuchs, K. Shuai, and D. E. Zhang. 2006. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25:2358–2367.
   PubMed Web of Science ®Google Scholar
• Malakhova, O. A., M. Yan, M. P. Malakhov, Y. Yuan, K. J. Ritchie, K. I. Kim, L. F. Peterson, K. Shuai, and D. E. Zhang. 2003. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev. 17:455–460.
   PubMed Web of Science ®Google Scholar
• Manns, M. P., J. G. McHutchison, S. C. Gordon, V. K. Rustgi, M. Shiffman, R. Reindollar, Z. D. Goodman, K. Koury, M. Ling, and J. K. Albrecht. 2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358:958–965.
   PubMed Web of Science ®Google Scholar
• Marin-Serrano, E., C. Rodriguez-Ramos, F. Diaz, L. Martin-Herrera, and J. A. Giron-Gonzalez. 2006. Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin. J. Viral Hepat. 13:230–234.
   PubMedGoogle Scholar
• McHutchison, J. G., S. C. Gordon, E. R. Schiff, M. L. Shiffman, W. M. Lee, V. K. Rustgi, Z. D. Goodman, M. H. Ling, S. Cort, J. K. Albrecht, et al. 1998. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med. 339:1485–1492.
   PubMed Web of Science ®Google Scholar
• Mowen, K. A., J. Tang, W. Zhu, B. T. Schurter, K. Shuai, H. R. Herschman, and M. David. 2001. Arginine methylation of STAT1 modulates IFNα/β-induced transcription. Cell 104:731–741.
   PubMed Web of Science ®Google Scholar
• Osiak, A., O. Utermohlen, S. Niendorf, I. Horak, and K. P. Knobeloch. 2005. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol. Cell. Biol. 25:6338–6345.
   PubMedGoogle Scholar
• Postic, C., M. Shiota, K. D. Niswender, T. L. Jetton, Y. Chen, J. M. Moates, K. D. Shelton, J. Lindner, A. D. Cherrington, and M. A. Magnuson. 1999. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knockouts using Cre recombinase. J. Biol. Chem. 274:305–315.
   PubMed Web of Science ®Google Scholar
• Randall, G., L. Chen, M. Panis, A. K. Fischer, B. D. Lindenbach, J. Sun, J. Heathcote, C. M. Rice, A. M. Edwards, and I. D. McGilvray. 2006. Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. Gastroenterology 131:1584–1591.
   PubMed Web of Science ®Google Scholar
• Rigopoulou, E. I., W. G. Abbott, P. Haigh, and N. V. Naoumov. 2005. Blocking of interleukin-10 receptor: a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus. Clin. Immunol. 117:57–64.
   PubMed Web of Science ®Google Scholar
• Ritchie, K. J., C. S. Hahn, K. I. Kim, M. Yan, D. Rosario, L. Li, J. C. de la Torre, and D. E. Zhang. 2004. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat. Med. 10:1374–1378.
   PubMed Web of Science ®Google Scholar
• Ritchie, K. J., M. P. Malakhov, C. J. Hetherington, L. Zhou, M. T. Little, O. A. Malakhova, J. C. Sipe, S. H. Orkin, and D. E. Zhang. 2002. Dysregulation of protein modification by ISG15 results in brain cell injury. Genes Dev. 16:2207–2212.
   PubMedGoogle Scholar
• Sarasin-Filipowicz, M., E. J. Oakeley, F. H. Duong, V. Christen, L. Terracciano, W. Filipowicz, and M. H. Heim. 2008. Interferon signaling and treatment outcome in chronic hepatitis C. Proc. Natl. Acad. Sci. USA 105:7034–7039.
   PubMed Web of Science ®Google Scholar
• Shen, X., F. Hong, V. A. Nguyen, and B. Gao. 2000. IL-10 attenuates IFN-α-activated STAT1 in the liver: involvement of SOCS2 and SOCS3. FEBS Lett. 480:132–136.
   PubMed Web of Science ®Google Scholar
• Shuai, K. 2000. Modulation of STAT signaling by STAT-interacting proteins. Oncogene 19:2638–2644.
   PubMed Web of Science ®Google Scholar
• Shuai, K., G. R. Stark, I. M. Kerr, and J. E. Darnell, Jr. 1993. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261:1744–1746.
   PubMed Web of Science ®Google Scholar
• Song, M. M., and K. Shuai. 1998. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273:35056–35062.
   PubMed Web of Science ®Google Scholar
• Starr, R., D. Metcalf, A. G. Elefanty, M. Brysha, T. A. Willson, N. A. Nicola, D. J. Hilton, and W. S. Alexander. 1998. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA 95:14395–14399.
   PubMed Web of Science ®Google Scholar
• ten Hoeve, J., M. de Jesus Ibarra-Sanchez, Y. Fu, W. Zhu, M. Tremblay, M. David, and K. Shuai. 2002. Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol. Cell. Biol. 22:5662–5668.
   PubMed Web of Science ®Google Scholar
• Wills, R. J. 1990. Clinical pharmacokinetics of interferons. Clin. Pharmacokinet. 19:390–399.
   PubMed Web of Science ®Google Scholar
• Yasukawa, H., M. Ohishi, H. Mori, M. Murakami, T. Chinen, D. Aki, T. Hanada, K. Takeda, S. Akira, M. Hoshijima, T. Hirano, K. R. Chien, and A. Yoshimura. 2003. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4:551–556.
   PubMed Web of Science ®Google Scholar
• Zou, W., J. H. Kim, A. Handidu, X. Li, K. I. Kim, M. Yan, J. Li, and D. E. Zhang. 2007. Microarray analysis reveals that type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages. Biochem. Biophys. Res. Commun. 356:193–199.
   PubMedGoogle Scholar